Lombard Odier Asset Management (Switzerland)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-71,180
| Closed | -$4.7M | – | 159 |
|
|
2023
Q1 | $4.7M | Sell |
71,180
-99,173
| -58% | -$6.54M | 0.41% | 68 |
|
|
2022
Q4 | $8.81M | Buy |
170,353
+40,776
| +31% | +$2.11M | 0.7% | 45 |
|
|
2022
Q3 | $8.85M | Sell |
129,577
-65,549
| -34% | -$4.48M | 0.75% | 43 |
|
|
2022
Q2 | $8.82M | Sell |
195,126
-26,125
| -12% | -$1.18M | 0.75% | 39 |
|
|
2022
Q1 | $11.2M | Sell |
221,251
-202,425
| -48% | -$10.3M | 0.88% | 42 |
|
|
2021
Q4 | $20M | Buy |
423,676
+216,930
| +105% | +$10.3M | 1.28% | 31 |
|
|
2021
Q3 | $6.81M | Sell |
206,746
-188,287
| -48% | -$6.21M | 0.42% | 73 |
|
|
2021
Q2 | $25M | Buy |
395,033
+15,638
| +4% | +$988K | 1.27% | 28 |
|
|
2021
Q1 | $16.3M | Buy |
+379,395
| New | +$16.3M | 1.08% | 36 |
|